Analytical Data
-
Gene name
CALPRO
- Application
-
Alternative Names
CALPRO；
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P05109
-
Expression Region
全长
-
AA Sequence
full
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CALPRO is a recombinant protein that has garnered significant interest in the field of biotechnology and medical research. The primary background for its study lies in the growing need for reliable biomarkers in the diagnosis and monitoring of gastrointestinal diseases, particularly inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. Traditional diagnostic methods are often invasive, time-consuming, and may not always provide accurate information about disease activity. CALPRO represents a novel approach as it can serve as a non-invasive biomarker, offering a straightforward method for assessing inflammation through stool samples. This protein is derived from the human body, enhancing its relevance and applicability in clinical settings. Research has shown that CALPRO levels correlate well with endoscopic findings and other markers of inflammation, making it a promising candidate for early diagnosis and ongoing monitoring of IBD. Furthermore, its specificity and sensitivity in distinguishing between different gastrointestinal disorders are under investigation, potentially paving the way for tailored therapeutic strategies. The advancement in recombinant technology has facilitated the mass production of CALPRO, making it more accessible for research and clinical applications. Overall, the study of CALPRO is poised to enhance the understanding of gastrointestinal diseases and improve patient outcomes through more precise and less invasive diagnostic practices.
